Shukra Pharmaceuticals Ltd (SHUKRAPHAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 505931, "name": "Shukra Pharma.", "stock_name": "Shukra Pharma.", "full_name": "Shukra Pharmaceuticals Ltd", "name_url": "stocks-analysis/shukra-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "55.96", "chg": 1.7, "chgp": "3.13%", "dir": 1, "prev_price": "54.26", "mcapval": "2,420.00 Cr", "mcap": "Micro Cap", "scripcode": 524632, "symbol": "SHUKRAPHAR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE551C01044", "curr_date": "Sep 18, 03:30 PM", "curr_time": "15:33 PM", "last_traded_at": "Sep 18, 03:30 PM IST", "bse_nse_vol": "4.05 lacs", "exc_status": "Active", "traded_date": "Sep 18, 2026", "traded_date_str": "2026 09 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Shukra Pharmaceuticals Gains 3.74%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-374-3-key-factors-driving-the-week-4198472", "imagepath": "", "date": "2026-09-19 17:02:45", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Mojo Grade downgraded to Hold amid mixed technicals and expensive valuation</p>\n <p><strong>16 Sep:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n <p><strong>18 Sep:</strong> Technical trend upgraded to bullish despite slight price dip</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.53.94</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.55.96</div><div class=\"stat-change positive\">+3.74%</..." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4196702", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4196702.png", "date": "2026-09-18 08:02:11", "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Sep 2026, the evolving technical indicators suggest a potential strengthening in price momentum, warranting close attention from investors and market analysts alike." }, { "title": "Shukra Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Expensive Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-downgraded-to-hold-amid-mixed-technicals-and-expensive-valuation-4194503", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4194503.png", "date": "2026-09-16 08:39:50", "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and impressive long-term returns, the stock’s technical indicators and premium valuation have prompted a more cautious stance." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4194090", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4194090.png", "date": "2026-09-16 08:04:20", "description": "Shukra Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. Despite a 2.5% gain on 16 Sep 2026, the stock’s technical indicators present a complex picture, with some weekly and monthly signals diverging. This article analyses the recent price action, key technical indicators, and the implications for investors amid the broader market context." }, { "title": "Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-381-3-key-factors-driving-the-move-4191585", "imagepath": "", "date": "2026-09-12 16:02:46", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> Stock opens at Rs.53.07, rising 2.14% despite Sensex decline</p>\n <p><strong>10 Sep:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n <p><strong>10 Sep:</strong> Mojo Grade upgraded from Hold to Buy on strong fundamentals</p>\n <p><strong>11 Sep:</strong> Technical momentum shifts to bullish despite minor price dip</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.51.96</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..." }, { "title": "Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4189909", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4189909.png", "date": "2026-09-11 08:10:01", "description": "Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4189758", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4189758.png", "date": "2026-09-11 08:02:20", "description": "Shukra Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a bullish trajectory. Despite a recent day decline of 4.23%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by strong moving averages and bullish signals on weekly charts. This analysis delves into the key technical parameters shaping investor sentiment and the stock’s potential trajectory in the Pharmaceuticals & Biotechnology sector." }, { "title": "Golden Cross Forms in Shukra Pharmaceuticals Ltd — On a Day the Stock Fell 4.2%. What the Mixed Signals Mean", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4189645", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_goldencross_4189645.png", "date": "2026-09-10 18:00:37", "description": "The 50-day moving average has crossed above the 200-day moving average for Shukra Pharmaceuticals Ltd, signalling a golden cross on 10 Sep 2026. Yet, the stock declined 4.23% on the same day, while monthly momentum indicators remain mildly bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal’s reliability." }, { "title": "Shukra Pharmaceuticals Surges 17.34%: Key Technical Shifts and Financials Drive Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-surges-1734-key-technical-shifts-and-financials-drive-rally-4183887", "imagepath": "", "date": "2026-09-05 17:07:53", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Stock opens at Rs.44.43 with mild bullish momentum</p>\n <p><strong>1 Sep:</strong> MarketsMOJO downgrades rating to Sell amid mixed technicals</p>\n <p><strong>2 Sep:</strong> Technical momentum shifts to mildly bearish; cautious trading</p>\n <p><strong>3 Sep:</strong> Strong price rally of 11.13%, technical momentum turns mildly bullish</p>\n <p><strong>4 Sep:</strong> MarketsMOJO upgrades rating to Hold; stock closes at Rs.51.96</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"s..." } ], "total": 674, "sid": "505931", "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931" }, "announcements": [ { "caption": "Reg. 34 (1) Annual Report.", "datetime": "05-Sep-2026", "details": "ANNUAL REPORT", "source": "BSE" }, { "caption": "AGM NOTICE", "datetime": "05-Sep-2026", "details": "AGM NOTICE", "source": "BSE" }, { "caption": "Update On Date Of AGM", "datetime": "03-Sep-2026", "details": "Update on Date of AGM", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 21 Sep 26", "dt": "2026-09-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25", "dt": "2025-03-21", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24", "dt": "2024-04-19", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23", "dt": "2023-02-02", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

15 Sep: Mojo Grade downgraded to Hold amid mixed technicals and expensive valuation

16 Sep: Technical momentum shifts to mildly bullish with mixed indicator signals

18 Sep: Technical trend upgraded to bullish despite slight price dip

+3.74%Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-18 08:02:11

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Sep 2026, the evolving technical indicators suggest a potential strengthening in price momentum, warranting close attention from investors and market analysts alike.

Read full news article

Shukra Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Expensive Valuation

2026-09-16 08:39:50

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and impressive long-term returns, the stock’s technical indicators and premium valuation have prompted a more cautious stance.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-16 08:04:20

Shukra Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. Despite a 2.5% gain on 16 Sep 2026, the stock’s technical indicators present a complex picture, with some weekly and monthly signals diverging. This article analyses the recent price action, key technical indicators, and the implications for investors amid the broader market context.

Read full news article

Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move

2026-09-12 16:02:46

Key Events This Week

7 Sep: Stock opens at Rs.53.07, rising 2.14% despite Sensex decline

10 Sep: Formation of Golden Cross signals potential bullish breakout

10 Sep: Mojo Grade upgraded from Hold to Buy on strong fundamentals

11 Sep: Technical momentum shifts to bullish despite minor price dip

Week Open

Rs.51.96

Week CloseRead full news article

Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals

2026-09-11 08:10:01

Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-11 08:02:20

Shukra Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a bullish trajectory. Despite a recent day decline of 4.23%, the stock’s technical indicators reveal a complex but predominantly positive outlook, supported by strong moving averages and bullish signals on weekly charts. This analysis delves into the key technical parameters shaping investor sentiment and the stock’s potential trajectory in the Pharmaceuticals & Biotechnology sector.

Read full news article

Golden Cross Forms in Shukra Pharmaceuticals Ltd — On a Day the Stock Fell 4.2%. What the Mixed Signals Mean

2026-09-10 18:00:37

The 50-day moving average has crossed above the 200-day moving average for Shukra Pharmaceuticals Ltd, signalling a golden cross on 10 Sep 2026. Yet, the stock declined 4.23% on the same day, while monthly momentum indicators remain mildly bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal’s reliability.